{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:35:41Z","timestamp":1773419741170,"version":"3.50.1"},"reference-count":30,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,4,1]]},"DOI":"10.1210\/jc.2003-031016","type":"journal-article","created":{"date-parts":[[2004,4,7]],"date-time":"2004-04-07T18:23:39Z","timestamp":1081362219000},"page":"1747-1752","source":"Crossref","is-referenced-by-count":56,"title":["Hyperparathyroidism-Jaw Tumor Syndrome in Roma Families from Portugal Is Due to a Founder Mutation of the HRPT2 Gene"],"prefix":"10.1210","volume":"89","author":[{"given":"Branca M.","family":"Cavaco","sequence":"first","affiliation":[{"name":"Centro de Investigac\u0327a\u0303o de Patobiologia Molecular, Instituto Portugue\u0302s de Oncologia de Francisco Gentil, Centro Regional de Oncologia de Lisboa, Sociedade Ano\u0301nima (B.M.C., M.-A.S., L.G.S., V.L.), 1099-023 Lisboa, Portugal"},{"name":"Molecular Endocrinology Group, Nuffield Department of Clinical Medicine, Botnar Research Center, Nuffield Orthopedic Center, University of Oxford (B.M.C., K.J.B., B.H., R.V.T.), Oxford, United Kingdom OX3 7LD"}]},{"given":"Laura","family":"Guerra","sequence":"additional","affiliation":[{"name":"Servic\u0327o de Endocrinologia, Hospital Curry Cabral (L.G.), 1069-166 Lisboa, Portugal"}]},{"given":"Karin J.","family":"Bradley","sequence":"additional","affiliation":[{"name":"Molecular Endocrinology Group, Nuffield Department of Clinical Medicine, Botnar Research Center, Nuffield Orthopedic Center, University of Oxford (B.M.C., K.J.B., B.H., R.V.T.), Oxford, United Kingdom OX3 7LD"}]},{"given":"Davide","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Servic\u0327o de Endocrinologia, Hospital de S. Joa\u0303o (D.C.), 4200 Porto, Portugal"}]},{"given":"Brian","family":"Harding","sequence":"additional","affiliation":[{"name":"Molecular Endocrinology Group, Nuffield Department of Clinical Medicine, Botnar Research Center, Nuffield Orthopedic Center, University of Oxford (B.M.C., K.J.B., B.H., R.V.T.), Oxford, United Kingdom OX3 7LD"}]},{"given":"Ame\u0301lia","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Centro de Sau\u0301de de Elvas (A.O.), 7350 Elvas, Portugal"}]},{"given":"Maria-Amparo","family":"Santos","sequence":"additional","affiliation":[{"name":"Centro de Investigac\u0327a\u0303o de Patobiologia Molecular, Instituto Portugue\u0302s de Oncologia de Francisco Gentil, Centro Regional de Oncologia de Lisboa, Sociedade Ano\u0301nima (B.M.C., M.-A.S., L.G.S., V.L.), 1099-023 Lisboa, Portugal"}]},{"given":"Lui\u0301s G.","family":"Sobrinho","sequence":"additional","affiliation":[{"name":"Centro de Investigac\u0327a\u0303o de Patobiologia Molecular, Instituto Portugue\u0302s de Oncologia de Francisco Gentil, Centro Regional de Oncologia de Lisboa, Sociedade Ano\u0301nima (B.M.C., M.-A.S., L.G.S., V.L.), 1099-023 Lisboa, Portugal"}]},{"given":"Rajesh V.","family":"Thakker","sequence":"additional","affiliation":[{"name":"Molecular Endocrinology Group, Nuffield Department of Clinical Medicine, Botnar Research Center, Nuffield Orthopedic Center, University of Oxford (B.M.C., K.J.B., B.H., R.V.T.), Oxford, United Kingdom OX3 7LD"}]},{"given":"Valeriano","family":"Leite","sequence":"additional","affiliation":[{"name":"Centro de Investigac\u0327a\u0303o de Patobiologia Molecular, Instituto Portugue\u0302s de Oncologia de Francisco Gentil, Centro Regional de Oncologia de Lisboa, Sociedade Ano\u0301nima (B.M.C., M.-A.S., L.G.S., V.L.), 1099-023 Lisboa, Portugal"}]}],"member":"80","reference":[{"key":"2019041116325544900_R1","first-page":"1397","article-title":"Parathyroid hormone, calcitonin and the calciferols","author":"Aurbach","year":"1992","journal-title":"In: Wilson JD, Foster D, eds. Textbook of endocrinology, 7th Ed. Philadelphia: Saunders;"},{"key":"2019041116325544900_R2","first-page":"187","article-title":"Familial hyperparathyroid syndromes","author":"Heath","year":"1996","journal-title":"In: Favus MJ, eds. Primer on metabolic bone disorders and disorders of mineral metabolism, 3rd Ed. Philadelphia: Lippincott-Raven;"},{"key":"2019041116325544900_R3","first-page":"1031","article-title":"Multiple endocrine neoplasia","author":"Thakker","year":"1988","journal-title":"In: Sheppard MC, eds. Molecular biology and endocrinology. London: Bailliere Tindall;"},{"key":"2019041116325544900_R4","first-page":"1989","article-title":"Genetic basis of endocrine disease: multiple endocrine neoplasia type 2.","volume":"80","author":"Mulligan","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041116325544900_R5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/qjmed\/89.9.653","article-title":"Clinical studies of multiple endocrine neoplasia type 1 (MEN1).","volume":"89","author":"Trump","year":"1996","journal-title":"Q J Med"},{"key":"2019041116325544900_R6","first-page":"489","article-title":"Multiple endocrine neoplasia type 1","author":"Marx","year":"1998","journal-title":"In: Vogelstein B, eds. The genetic basis of human cancer. New York: McGraw-Hill;"},{"key":"2019041116325544900_R7","first-page":"67","article-title":"Multiple endocrine neoplasia.","volume":"56","author":"Thakker","year":"2001","journal-title":"Horm Res"},{"key":"2019041116325544900_R8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-200201000-00001","article-title":"Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds.","volume":"81","author":"Simonds","year":"2002","journal-title":"Medicine"},{"key":"2019041116325544900_R9","first-page":"1006","article-title":"Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome.","volume":"108","author":"Jackson","year":"1990","journal-title":"Surgery"},{"key":"2019041116325544900_R10","first-page":"944","article-title":"Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21\u2013q31.","volume":"56","author":"Szabo","year":"1995","journal-title":"Am J Hum Genet"},{"key":"2019041116325544900_R11","first-page":"4204","article-title":"Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21\u2013q32 and loss of the wild type allele in renal hamartomas.","volume":"81","author":"Teh","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041116325544900_R12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/qjmed\/94.4.213","article-title":"The hyperparathyroidism-jaw tumor syndrome in a Portuguese kindred.","volume":"94","author":"Cavaco","year":"2001","journal-title":"Q J Med"},{"key":"2019041116325544900_R13","first-page":"2114","article-title":"Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21\u2013q32 in a subset of families.","volume":"83","author":"Teh","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041116325544900_R14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2265.1999.00633.x","article-title":"Genetic studies of a family with hereditary hyperparathyroidism-jaw tumor syndrome.","volume":"50","author":"Wassif","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041116325544900_R15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1086\/302259","article-title":"Hyperparathyroidism-jaw tumor syndrome: the HRPT2 locus is within a 0.7-cM region on chromosome 1q.","volume":"64","author":"Hobbs","year":"1999","journal-title":"Am J Hum Genet"},{"key":"2019041116325544900_R16","first-page":"1449","article-title":"A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome.","volume":"85","author":"Haven","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041116325544900_R17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2169\/internalmedicine.33.123","article-title":"Familial primary hyperparathyroidism complicated with Wilms\u2019 tumor.","volume":"33","author":"Kakinuma","year":"1994","journal-title":"Intern Med"},{"key":"2019041116325544900_R18","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome.","volume":"32","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"key":"2019041116325544900_R19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmg.40.9.657","article-title":"HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours.","volume":"40","author":"Howell","year":"2003","journal-title":"J Med Genet"},{"key":"2019041116325544900_R20","first-page":"48","article-title":"Tumours of the parathyroid glands","author":"Solcia","year":"2000","journal-title":"In: WHO, eds. Histological typing of endocrine tumours, 2nd Ed. New York: Springer;"},{"key":"2019041116325544900_R21","first-page":"53","article-title":"Tumors of the parathyroid gland","author":"DeLellis","year":"1993","journal-title":"In: Rosai J, eds. Atlas of tumor pathology. Washington, DC: Armed Forces Institute of Pathology;"},{"key":"2019041116325544900_R22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1056\/NEJM198907273210403","article-title":"Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11.","volume":"321","author":"Thakker","year":"1989","journal-title":"N Engl J Med"},{"key":"2019041116325544900_R23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0046-8177(94)90219-4","article-title":"Extraction of DNA from paraffin-embedded tissue for analysis by polymerase chain reaction: new tricks from an old friend.","volume":"25","author":"Shibata","year":"1994","journal-title":"Hum Pathol"},{"key":"2019041116325544900_R24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2265.1996.d01-1561.x","article-title":"Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours.","volume":"45","author":"Pearce","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041116325544900_R25","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/BF02346182","article-title":"Genetic mapping studies of 40 loci and 23 cosmids in chromosome 11p13\u201311q13, and exclusion of \u03bc-calpain as the multiple endocrine neoplasia type 1 gene.","volume":"97","author":"Pang","year":"1996","journal-title":"Hum Genet"},{"key":"2019041116325544900_R26","first-page":"4371","article-title":"Somatic mutations in MEN type 1 tumors, consistent with the Knudson \u201ctwo-hit\u201d hypothesis.","volume":"86","author":"Pannett","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041116325544900_R27","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1172\/JCI116524","article-title":"Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations.","volume":"91","author":"Thakker","year":"1993","journal-title":"J Clin Invest"},{"key":"2019041116325544900_R28","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/hmg\/3.8.1303","article-title":"Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype.","volume":"3","author":"Crossey","year":"1994","journal-title":"Hum Mol Genet"},{"key":"2019041116325544900_R29","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1046\/j.1365-2265.2003.01765.x","article-title":"Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism.","volume":"58","author":"Pannett","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041116325544900_R30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1086\/301729","article-title":"Characterization of mutations in patients with multiple endocrine neoplasia type 1.","volume":"62","author":"Bassett","year":"1998","journal-title":"Am J Hum Genet"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/89\/4\/1747\/10743579\/jcem1747.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T01:46:58Z","timestamp":1555033618000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/89\/4\/1747\/2844402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,1]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2003-031016","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,1]]}}}